Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study

By sjmartinez • December 24, 2025

Abe K, Holmes TH, Nguyen TT; IMPACC Network; Kim-Schulze S, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA, Sekaly RP, Cairns CB, Haddad EK, Shaw AC, Hafler DA, Montgomery RR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Agudelo Higuita NI, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Fernandez-Sesma A, Simon V, Kraft M, Bime C, Calfee CS, Erle DJ, Schaenman J, Reed EF, Ozonoff A, Peters B, Kleinstein SH, Augustine AD, Diray-Arce J, Becker PM, Rouphael N, Maecker HT. Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. J Immunol. 2025 Dec 1;214(12):3310-3320. doi: 10.1093/jimmun/vkaf263. PMID: 41166719; PMCID: PMC12726064.

Tags: Cytokines, human, Infectious Diseases, Inflammation, Molecular biology, Publications, viral

SPHERES: innovative registry addressing the new era of neuromyelitis optica spectrum disorders (NMOSD) therapy

Bennett JL, Middaugh N, Yeaman MR, Smith TJ, Behne MK, Crabtree M, McLean RR, Pappas DA, Levy M. SPHERES: innovative registry addressing the new era[...]

A pilot intervention to improve the management of urinary tract infections in outpatient settings

Madaras-Kelly KJ, Nakasone T, Maghari S, Taylor J, Nevers M, Crook J, Brintz B, Braunfeld JB, Goetz MB, Samore M. A pilot intervention to improve[...]

Phylodynamic analysis reveals disparate transmission dynamics of Mycobacterium tuberculosis complex lineages in Botswana

Wang Q, Barilar I, Minin VM, Modongo C, Moonan PK, Finlay A, Boyd R, Oeltmann JE, Molefi TL, Zetola NM, Brewer TF, Niemann S, Shin[...]